Biphenotypic hybrid acute leukaemia detected by two colour flow cytometry

H R Gudum1, Y M Chin, N Menaka

  • 1Haematology Division, Institute for Medical Research, Kuala Lumpur, Malaysia.

Insights

Biphenotypic hybrid acute leukaemia, characterized by co-expressed lymphoid and myeloid markers, is not rare. Immunophenotyping is crucial for identifying this subtype, which may impact treatment effectiveness.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Acute leukaemia classification relies on morphology and cytochemistry.
  • Immunophenotyping offers a more detailed analysis of cell surface markers.
  • Biphenotypic acute leukaemias present diagnostic challenges.

Purpose of the Study:

  • To identify and characterize biphenotypic hybrid acute leukaemia in Malaysian patients.
  • To evaluate the utility of immunophenotyping in classifying acute leukaemia.
  • To highlight the clinical significance of recognizing biphenotypic acute leukaemia.

Main Methods:

  • Immunofluorescent flow cytometry was used.
  • A panel of eight monoclonal antibodies was employed.
  • Blast cells from 36 acute leukaemia patients were analyzed.

Main Results:

  • Six patients (16.7%) were diagnosed with biphenotypic hybrid acute leukaemia.
  • These cases showed co-expression of lymphoid and myeloid markers.
  • Extensive bone marrow infiltration (>75% blasts) was observed in all biphenotypic cases.

Conclusions:

  • Biphenotypic hybrid acute leukaemia is an identifiable subgroup, not rare in Malaysia.
  • Immunophenotyping is superior to morphology-based classifications for this subtype.
  • Accurate identification impacts treatment strategies and patient outcomes.

Related Concept Videos